GRIM
DGX icon

Greenhaven Road Investment Management’s Quest Diagnostics DGX Stock Holding History

Greenhaven Road Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,339
Closed -$173K – 48
2021
Q3 		$173K Sell
28,339
-2,012
-7% -$294K 0.03% 37
2021
Q2 		$67K Sell
30,351
-6,709
-18% -$878K 0.01% 32
2021
Q1 		$145K Buy
+37,060
New +$4.57M 0.03% 20

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Greenhaven Road Investment Management's DGX Position: Q4 2021 in Review

Greenhaven Road Investment Management sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 28,339 shares — an estimated $173K sold.

Greenhaven Road Investment Management first reported a position in DGX in Q1 2021 and held it in 3 quarters. The position peaked at $173K in Q3 2021. 906 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Greenhaven Road Investment Management reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Greenhaven Road Investment Management sold 28,339 Quest Diagnostics shares in Q4 2021, an estimated $173K.
  • Greenhaven Road Investment Management first reported a position in Quest Diagnostics in Q1 2021 and held it in 3 quarters.
  • Greenhaven Road Investment Management's Quest Diagnostics position peaked at $173K in Q3 2021.
  • 906 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Greenhaven Road Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.